Legal Opinion
Teva Pharmaceuticals, Industries, Ltd. v. Food & Drug Administration
District Court, District of Columbia
Decided December 23, 2004No. CIV.A.04-1416(RBW)PublishedCited by 11 opinions
1Opinion of the Court
MEMORANDUM OPINION
WALTON, District Judge.
The plaintiffs filed this action to challenge a decision by the Food and Drug Administration (“FDA”), which permits the sale of brand generic drugs 1 during the generic exclusivity period provided for in 21 U.S.C. § 355(j)(5)(B)(iv)(I). Verified Amended Complaint (“Compl.”) ¶¶ 119-24. 2 The parties have filed cross-motions for summary judgment. Currently before the Court are (1) the Plaintiffs’ Memorandum of Law in Support of Their Motion for Partial Summary Judgment (“Pis.’ Mem.”); (2) the Federal Defendants’ Memorandum in Support of Motion to Dismiss…
2Cases cited24 opinions
- Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
- Citizens to Preserve Overton Park, Inc. v. VolpeSupreme Court of the United States · 1971
- United States v. Ron Pair Enterprises, Inc.Supreme Court of the United States · 1989
- United States v. Mead Corp.Supreme Court of the United States · 2001
- Lamie v. United States TrusteeSupreme Court of the United States · 2004
19 more not listed; retrieve them via the Exa API.
3Cited by11 opinions
- Hi-Tech Pharmacal Co. v. United States Food & Drug AdministrationDistrict Court, District of Columbia · 2008
- Teva Pharmaceutical Industries Ltd. v. CrawfordCourt of Appeals for the D.C. Circuit · 2005
- Connecticut v. U.S. Dep't of the InteriorCourt of Appeals for the D.C. Circuit · 2018
- Jolevare v. Alpha Kappa Alpha Sorority, Inc.District Court, District of Columbia · 2007
- Veloxis Pharmaceuticals, Inc. v. United States Food and Drug AdministrationDistrict Court, District of Columbia · 2015
6 more not listed; retrieve them via the Exa API.